Steven T. Forman, MD, FACC

Dr. Steven T. FormanDr. Steven Forman joined Los Alamitos Cardiovascular in 1999, and has been its managing partner since 2005. In addition to his roles at Los Alamitos Cardiovascular, Dr. Forman is director of the Performance Vein Institute of Los Alamitos—a practice focused on medical and cosmetic vein treatments.

Recognizing that each patient's needs are unique is one of the most important aspects of practicing good medicine. That understanding requires a professional commitment to engage every patient in a special, working partnership in order to ensure the finest care be given at all times...

On Medicine
Medicine is often referred to as an art, as well as a science. In order to be the best physician possible, it is not enough to be a strict scientist: One truly needs to be an artist, as well.

On Los Alamitos Cardiovascular
Our primary goal is to provide the highest quality and most comprehensive cardiovascular and endovascular care available. To meet this goal, we employ an excellent group of doctors, who are supported by a dedicated staff.

On My Specialty
Innovations in cardiovascular and endovascular medicine are at the forefront of medical technology, today. As a doctor in these fields, I am seeing both immediate, and imminent benefits to our patients. This is a very exciting time to be a physician within my chosen specialties of practice...

Dr. Steven T. Forman's Curriculum Vitae

Printable VersionView Printable CV
Specialty: Cardiology, Interventional Cardiology, Endovascular Diseases
Post Doctoral Training:
  • Fellow in Interventional Cardiology
    The Division of Cardiology
    The New York Hospital – Cornell University Medical Center
    New York, New York
    July 1997 – June 1998

  • Fellow in Cardiology
    The New York Hospital – Cornell University Medical Center
    New York, New York
    July 1994 – June 1997

  • Intern/Resident in Internal Medicine
    Department of Medicine
    Thomas Jefferson University Hospital
    Philadelphia, Pennsylvania
    July 1991 – June 1994

Education:
  • Albany Medical College
    Albany, New York
    MD, May 1991
  • The Johns Hopkins University
    Baltimore, Maryland
    BA, Natural Science, May 1987
Academic Appointments: Instructor in Medicine
Department of Medicine
The New York Hospital – Cornell University Medical Center
June 1996 – June 1998
Current Hospital Appointments:
  • Los Alamitos Medical Center
    3751 Katella Avenue
    Los Alamitos, California 90720

  • Long Beach Memorial Medical Center
    2801 Atlantic Avenue
    Long Beach, California 90801

  • Lakewood Regional Medical Center
    3700 South Street
    Lakewood, California 90712

Committees/
Appointments

  • Chairman of Department of Medicine
    Los Alamitos Medical Center, January 2007 – present

  • Chairman of Allied Health Committee
    Los Alamitos Medical Center, January 2006 – December 2006

  • Member, Medical Executive Committee
    Los Alamitos Medical Center, January 2006 – present

  • Member, Myocardial Infarction Quality Assurance Committee
    Los Alamitos Medical Center, January 2001 – present

  • Member, Cardiovascular Quality Assurance Committee
    Long Beach Memorial Medical Center, January 2000 – present

Previous Hospital Appointments:
  • General Hospital of Passaic
    350 Boulevard
    Passaic, New Jersey 07055
    July 1998 – August 1999

  • Saint Mary’s Hospital
    211 Pennington Avenue
    Passaic, New Jersey 07055
    July 1998 – August 1999

  • Saint Joseph’s Hospital and Medical Center
    703 Main Street
    Passaic, New Jersey 07055
    July 1998 – August 1999

  • Chilton Memorial Hospital
    97 West Parkway
    Pomptom Plains, New Jersey 07444
    July 1998 – August 1999

  • Passaic Beth Israel Hospital
    70 Parker Avenue
    Passaic, New Jersey 07055
    July 1998 – August 1999

Prior Employment:
  • Cardiology Associates of North Jersey
    1030 Clifton Avenue
    Clifton, New Jersey 07013
    July 1998 – August 1999

  • Urgent Care Physician
    Memorial Sloan Kettering Cancer Center
    New York, New York
    July 1994 – June 1996

Board Certifications:
  • American Board of Internal Medicine
    Certified in Internal Medicine
    1994 (Recertification 2004)

  • American Board of Internal Medicine
    Certified in Cardiovascular Disease
    1997 (Recertification 2004)

  • American Board of Internal Medicine
    Certified in Interventional Cardiology
    1999 (Recertification 2009)

Professional Societies:
  • American College of Cardiology, Fellow (FACC)
  • American College of Physician, Member
  • Society of Cardiovascular CT, Member
  • Los Angeles County Medical Association, Member
  • American Medical Association, Member
Publications:
  • Novel distal occluder washout methods for prevention of no-reflow during stenting of saphenous vein grafts. Shaknovich A, Forman ST, Parikh M, Deutsch E, Bergman G, McCaffery T, Newman GC, Tarazona N and Sanborn T. Catheter Cardiovascular Intervention 1999 Aug: 47(4): 397 – 403.

  • Adenosine radionuclide perfusion imaging in the preoperative evaluation of patients undergoing peripheral vascular Surgery Marshall ES, Raichlen JS, Forman S, Heyrich GP, Keen WD, Weitz HH. American Journal of Cardiology 1995 Oct 15: 76(11):817 – 821.

Additional Research Experience:
  • Systolic and diastolic myocardial dysfunction during endotoxemia in pigs. Proctor: Roy D Goldfarb, Phd
    Department of Physiology, Albany Medical College, 1989 - 1991

  • A Phase III, double-blind, randomized placebo-controlled study, to evaluate the effects of dalcetrapib on cardiovascular (CV) risk in stable CHD patients, with a documented recent Acute Coronary Syndrome (ACS).
    Sponsor: F.Hoffmann-La Roche Ltd. Hoffmann-La Roche, Inc. Roche Global Development

  • A Multi-center, Randomized, Controlled Study to Investigate the Safety and Tolerability of Intravenous Ferric Carboxymaltose (FCM) vs. Iron Dextran in treating Iron Deficiency Anemia in Subjects Who Are Not Dialysis Dependent.
    Sponsor: Luitpold Pharmaceuticals, Inc.
  • A Phase3, randomized, Double-Blind, Double-Dummy, Parallel Group, Multi-Center, Multi-National Study for Evaluation of Efficacy and Safety of DU-176B Versus Warfarin in Subjects with Atrial Fibrillation - Effective aNticoaGulation with xA next Generation in Aterial Fibrillation. (ENGAGE-AF).
    Sponsor: Daiichi Sankyo Pharma Development

  • Freedom - A Frequent Optimization Study the Quick Opt ™ Method.
    St Jude

  • Registry of AT/AF Episodes in the CRM Device Population: Rate Registry.
    St. Jude

  • PA 32540-302: A 6-Month, Phase 3, Randomized, Double-Blind, Parallel-Group, Controlled, Multi-Center Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated Ulcers.